DiscoverStartupsONL TherapeuticsONL Therapeutics Funding Rounds, Valuation & Investors
ONL Therapeutics company logo
ONL Therapeutics
Protecting the vision of patients with retinal disease1-10 Employees
  • B2B
  • Scale Stage
    Rapidly increasing operations
View 0 jobs

ONL Therapeutics Funding

$7.5M
22 rounds
ONL Therapeutics is active in the following markets / industries: biotechnology. The company has secured funding across 2 rounds and is valued at $7.5M. Their most recent funding was raised on May 17, 2017.

Funding Rounds

A
$4255000
Series AMay 2017$7.5M valuation
Avatar for University of Michigan
+1
Press
ONL Therapeutics Closes Series A Financing to Support Development of Novel Retinal Cell Protection Platform for Treatment of Ocular Diseases
S
$1100000
SeedJun 2014$0 valuation

Investors of ONL Therapeutics

University of Michigan
VC Firm • Ann Arbor
Avatar for University of Michigan
Rounds
A
The Massachusetts Eye and Ear Infirmary
VC Firm
Rounds
A
Invest Michigan
VC Firm
Rounds
A
Biosciences Research & Commercialization Center
VC Firm
Rounds
A
Novartis Institutes for BioMedical Research
VC Firm
Rounds
A
Hirak Parikh
Angel Investor
Avatar for Hirak Parikh
Early-stage life science investor focussing on University spinouts
Back to People
Onwards to Jobs